Emerson: Predictive intelligence to reduce operating costs at biopharmaceutical plant
Predictive intelligence software, which anticipates what needs to be done to maintain optimal operations, will be used in a new $350 million Lonza biopharmaceutical plant in Singapore, with help from Emerson Process Management.
Predictive intelligence software, which
anticipates what needs to be done to maintain optimal operations, will be used
in a new $350 million Lonza biopharmaceutical plant in Singapore, with help from Emerson Process Management.
Predictive intelligence technology , software
that anticipates what needs to be done to maintain optimal operations, will be
used in a new Lonza biopharmaceutical plant in Singapore. Switzerland-based Lonza Group Ltd.
Selected Emerson Process Management to provide engineering and design services
and digital automation architecture and control technologies.
Competitive pressures drive life sciences
companies toward digital automation with predictive intelligence to reduce
overall costs, improve reliability, ensure product quality, meet regulatory
requirements, and optimize operations, says Emerson of its increasing number of
life sciences customers.
practices reduce costs in second Lonza plant
Having installed the automation architecture
in Lonza's first biopharmaceutical plant in Singapore, Emerson PlantWeb technologies were chosen
for the new plant, expected to be completed in 2010 at a cost of $350 million.
By following the original project models, employing best practices, and
applying the experience gained during design and construction of the original
facility, Emerson is expected to reduce Lonza's overall costs for the new
Lonza uses Emerson products and services,
including: PlantWeb digital automation architecture; DeltaV digital automation
system; and intelligent digital devices, including Fisher and Baumann control
valves with Fieldvue digital valve controllers, Rosemount flowmeters and
analyzers, Micro Motion Coriolis flowmeters, and Fisher pressure regulators.
startups, greater reliability cited
Managing and controlling the highly complex
processes involved in the biopharmaceutical industry is among Emerson
strengths, says Steve Sonnenberg, president, Emerson Process Management. Global
resources of Emerson help meet customers' objectives for safe, reliable, and
on-time start-up of new manufacturing facilities, he says.
In the Asia-Pacific region, Emerson also has
been awarded automation contracts by Shanghai CP Guojian Pharmaceutical Co.
Ltd. in China; Reliance Life Sciences, DSM
Anti-Infectives India Ltd., and Biocon in India; and the prior Lonza facility in Singapore.
For other recent Emerson news from
security: Safety instrumented systems, 5 incidents
buzz: Not all wireless was created equal
operations management: Emerson touts new software as MES
- Edited by Mark T. Hoske, electronic products editor, MBT, www.mbtmag.com